Sign in
4

Changes in Ownership

Mirum Pharmaceuticals, Inc. Filed Acc 0001209191-23-030966

Chief Development Officer acquired 684 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Longpre Lara Chief Development Officer 2023-05-10 Grant or award +684 $16.92 $11,576 106,843 D: show line 1 in the form
Loading xslF345X04/doc4.xml…